Development of selective inhibitors against plasma kallikrein
Specific plasma kallikrein inhibitors were designed and synthesized and their structure-activity relationship was studied. trans-4-Aminomethylcyclohexanecarbonyl(Tra)-lysyl-4-ethoxycarbonylanili de inhibited plasma kallikrein and plasmin with 1C50/s